Stoke Therapeutics
Zachary Patron has had a diverse range of work experiences in the biomedical field. Zachary'smost recent position was as a Research Associate at Stoke Therapeutics, starting in March 2020. Prior to that, from September 2019 to March 2020, they worked as an Associate Scientist at Cyteir Therapeutics, where they focused on finding and validating new potential targets for the company's synthetic lethality approach. Zachary also has experience as a Process Development Associate at the Broad Institute of MIT and Harvard, where they contributed to genomic sequencing projects and played a role in the Count Me In initiative. In 2015, they interned as a Respiratory Disease Intern at Novartis, and in 2013, they interned as an Electrophysiology Intern at Flatley Discovery Lab, where they were involved in ion channel research and drug discovery.
Zachary Patron completed their Bachelor of Science degree in Biology at the University of Massachusetts Amherst in 2018.